These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 532592)

  • 21. Biochemical analysis of bone compacta in osteogenesis imperfecta.
    Brenner RE; Vetter U; Wörsdorfer O; Nerlich A; Teller WM; Müller PK
    Ann N Y Acad Sci; 1988; 543():106-8. PubMed ID: 3214048
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.
    Arikoski P; Silverwood B; Tillmann V; Bishop NJ
    Bone; 2004 Mar; 34(3):539-46. PubMed ID: 15003801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease.
    Lowery WD; Thomas CG; Awbrey BJ; Rosenstein BD; Talmage RV
    Surgery; 1986 Dec; 100(6):1142-9. PubMed ID: 3787472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the mineral content of peripheral bones (radius) by photon-absorption technique in normals as well as in patients with various types of bone diseases (author's transl)].
    Runge H; Fengler F; Franke J; Koall W
    Radiologe; 1980 Oct; 20(10):505-14. PubMed ID: 7444044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term treatment of osteogenesis imperfecta tarda in adults with salmon calcitonin and calcium.
    Zanzi I; Wallach S; Ellis KJ; Aloia JF; Atkins HL; Cohn SH
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):189-97. PubMed ID: 813957
    [No Abstract]   [Full Text] [Related]  

  • 26. [Calciotropic hormones in osteoporosis caused by anorexia nervosa].
    Saggese G; Bertelloni S; Baroncelli GI; Ghirri P; Cosenza GM; Buggiani B
    Minerva Pediatr; 1989 Feb; 41(2):61-5. PubMed ID: 2786986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomographic assessment of vertebral bone mineral in childhood.
    Fredericks BJ; de Campo JF; Sephton R; McCredie DA
    Skeletal Radiol; 1990; 19(2):99-102. PubMed ID: 2321051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
    Rico H; Revilla M; Iritia M; Arribas I; Fernando Villa L
    Miner Electrolyte Metab; 1991; 17(6):396-8. PubMed ID: 1823391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteogenesis imperfecta clinical features, hearing loss and stapedectomy. Biochemical, osteodensitometric, corneometric and histological aspects in comparison with otosclerosis.
    Pedersen U
    Acta Otolaryngol Suppl; 1985; 415():1-36. PubMed ID: 3859176
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanical and mineral properties of osteogenesis imperfecta human bones at the tissue level.
    Imbert L; Aurégan JC; Pernelle K; Hoc T
    Bone; 2014 Aug; 65():18-24. PubMed ID: 24803077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical investigation in metabolic bone disease. Quantitative measurements of bone mineral.
    Evens RG; Pak CY; Ashburn W; Bartter FC
    Invest Radiol; 1969; 4(6):364-9. PubMed ID: 5368348
    [No Abstract]   [Full Text] [Related]  

  • 32. New approaches to treatment of osteogenesis imperfecta.
    Castells S
    Clin Orthop Relat Res; 1973 Jun; (93):239-49. PubMed ID: 4353023
    [No Abstract]   [Full Text] [Related]  

  • 33. Electron microscopic and histochemical investigation of osteogenesis imperfecta tarda.
    Doty SB; Mathews RS
    Clin Orthop Relat Res; 1971 Oct; 80():191-201. PubMed ID: 5133325
    [No Abstract]   [Full Text] [Related]  

  • 34. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral content and fragility fractures.
    Nilsson BE; Westlin NE
    Clin Orthop Relat Res; 1977 Jun; (125):196-9. PubMed ID: 880766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chamber analysis and study of the metabolism of strontium-85 in osteogenesis imperfecta. I. Chamber model of strontium-calcium metabolism in humans].
    Likhtarev IA; Krasnoshchekova GP; Dobroskok AI
    Med Radiol (Mosk); 1972 Jan; 17(1):70-6. PubMed ID: 5029608
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
    Paschalis EP; Gamsjaeger S; Fratzl-Zelman N; Roschger P; Masic A; Brozek W; Hassler N; Glorieux FH; Rauch F; Klaushofer K; Fratzl P
    J Bone Miner Res; 2016 May; 31(5):1050-9. PubMed ID: 26748579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsant drugs and bone metabolism.
    Bogliun G; Beghi E; Crespi V; Delodovici L; d'Amico P
    Acta Neurol Scand; 1986 Oct; 74(4):284-8. PubMed ID: 3811834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism.
    Diamond T; Nery L; Posen S
    Ann Intern Med; 1989 Oct; 111(7):567-73. PubMed ID: 2774387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal plasma levels of calcitonin and bone mineral mass in normal and uremic women. Effect of menopause.
    Corghi E; Ortolani S; Bianchi ML; Favini P; Vigo P; Polli EE
    Biomed Pharmacother; 1984; 38(5):263-5. PubMed ID: 6525424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.